Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Signal Detection Report: Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis — Misty Pratt (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Signal Detection Report: Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
Shared by
David Moher
Signal Detection Report: Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
Article
2017
en
Authors
+3 more
MP
Misty Pratt
NA
Nadera Ahmadzai
BH
Brian Hutton
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
Frank Tacke
,
Ralf Weiskirchen
Article
2018
Parental non‐alcoholic fatty liver disease increases risk of non‐alcoholic fatty liver disease in offspring
Michelle T. Long
,
Ellen B. Gurary
,
Joseph M. Massaro
,
Jiantao Ma
,
Udo Hoffmann
,
Raymond T. Chung
,
Emelia Benjamin
,
Rohit Loomba
Article
2019
Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease
Flora Tzifi
,
Andreas Fretzayas
,
George Chrousos
,
Christina Kanaka‐Gantenbein
Dataset
Faculty Opinions recommendation of Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.
Ralf Weiskirchen
Article
2021
Fructose and Non-Alcoholic Steatohepatitis
Elke Roeb
,
Ralf Weiskirchen
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.